Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis

E Sbidian, A Chaimani, R Guelimi… - Cochrane Database …, 2023 - cochranelibrary.com
Background Psoriasis is an immune‐mediated disease with either skin or joints manifestations,
or both, and it has a major impact on quality of life. Although there is currently no cure for …

Interventions for necrotizing soft tissue infections in adults

C Hua, R Bosc, E Sbidian, N De Prost… - Cochrane Database …, 2018 - cochranelibrary.com
Background Necrotizing soft tissue infections (NSTIs) are severe and rapidly spreading soft
tissue infections of the subcutaneous tissue, fascia, or muscle, which are mostly caused by …

Kawasaki disease in adults: observations in France and literature review

…, JM Galempoix, S Humbert, P Humbert, E Sbidian… - Autoimmunity …, 2016 - Elsevier
Objective Kawasaki disease (KD) is a vasculitis that mostly occurs in young children and
rarely in adults. We analyzed the characteristics of adult-onset KD (AKD) in France. Methods …

Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients

…, F Cuenot, L Penso, P Herlemont, E Sbidian… - …, 2021 - Am Heart Assoc
After initially hypothesizing a positive relationship between use of renin-angiotensin-aldosterone
system inhibitors and risk of coronavirus disease 2019 (COVID-19), more recent …

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

…, P Wolkenstein, P Grimbert, E Sbidian - Scientific Reports, 2022 - nature.com
Increasing number of Janus kinase (JAK) inhibitors have been approved for chronic
haematopoietic neoplasms and inflammatory/autoimmune diseases. We aimed to assess safety of …

Impact of STROBE Statement Publication on Quality of Observational Study Reporting: Interrupted Time Series versus Before-After Analysis

S Bastuji-Garin, E Sbidian, C Gaudy-Marqueste… - PloS one, 2013 - journals.plos.org
Background In uncontrolled before-after studies, CONSORT was shown to improve the
reporting of randomised trials. Before-after studies ignore underlying secular trends and may …

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France

TA Duong, E Sbidian, L Valeyrie-Allanore… - Orphanet Journal of …, 2011 - Springer
Background Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown
in one study to be associated with a 15-year decrease in life expectancy. However, data …

Association between adult acne and dietary behaviors: findings from the NutriNet-Santé Prospective Cohort Study

…, S Hercberg, K Ezzedine, E Sbidian - JAMA …, 2020 - jamanetwork.com
Importance Acne is a chronic, multifactorial inflammatory disease. The association between
consumption of dairy products and fatty and sugary foods and occurrence and progression …

Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a …

…, R Dray-Spira, A Weill, M Zureik, E Sbidian - Annals of the …, 2023 - ard.bmj.com
Objectives To assess the risk of major adverse cardiovascular events (MACEs) and venous
thromboembolism events (VTEs) among patients initiating a Janus kinase inhibitor (JAKi) (…

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

O Zehou, E Fabre, L Zelek, E Sbidian… - Orphanet journal of rare …, 2013 - Springer
Background Neurofibromatosis 1 (NF1) is the most common autosomal dominant disorder,
with an incidence of 1 in 2,500-3,300 live births. NF1 is associated with significant morbidity …